Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology ( ACR ) Convergence Meeting

Benzinga
2025.10.22 14:38
portai
I'm PortAI, I can summarize articles.

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Nkarta, Inc. ( NASDAQ:NKTX ) , a clinical-stage biopharmaceutical company developing engineered natural killer ( NK ) cell therapies to treat autoimmune disease, today announced it will be presenting a poster this Sunday in Chicago ...

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer